Korsgaard S, Skausig O B
Acta Psychiatr Scand. 1979 Feb;59(2):139-44. doi: 10.1111/j.1600-0447.1979.tb06955.x.
A trial has been performed investigating changes in weight in 99 female patients who have been treated with clopenthixol decanoate or perpehnazine enanthate after prior treatment with different oral neuroleptics. We found a significantly higher mean weight after the oral treatment period and a slight, but not statistically significant, further weight increase after the following depot period. In addition the rate of increase in weight was significantly lower during the depot treatment period. These increases might be due to achievement of a steady-state in weight during the first treatment period with oral intake. We found no difference between clopenthixol decanoate and perphenazine enanthate as regards change in weight or rate of change in weight.
一项试验对99名女性患者进行了研究,这些患者在先前接受不同口服抗精神病药物治疗后,又接受了癸酸氯哌噻吨或庚酸奋乃静治疗,观察其体重变化。我们发现口服治疗期后的平均体重显著更高,在随后的长效注射期后体重有轻微增加,但无统计学意义。此外,长效注射治疗期体重增加率显著更低。这些体重增加可能是由于在口服治疗的第一个阶段体重达到了稳态。在体重变化或体重变化率方面,我们发现癸酸氯哌噻吨和庚酸奋乃静之间没有差异。